Leadership
Our company is at the forefront of the biomedical research industry thanks to professionals who have had more than 30 years of medical and research experience.
Contact Us
Comprehensive Focus on Neurodegenerative Diseases
RBI targets a wide range of challenging conditions, including Alzheimer's, ALS, multiple sclerosis, Parkinson's disease and its variants, stroke, and traumatic brain injury (including CTE). This broad focus positions RBI at the forefront of addressing some of the most debilitating and currently incurable diseases.
Experienced Leadership and Research Team
With over 30 years of medical and research experience, RBI's team brings a wealth of expertise to their work. Their extensive knowledge and innovative approach enhance the company's ability to develop groundbreaking treatments and move swiftly through clinical trial phases.
Innovative Stem Cell Therapy Techniques
RBI has developed a cutting-edge method of injecting stem cells directly into the brain to treat neurodegenerative diseases. This precise technique aims to place stem cells where they are most needed to achieve optimal efficacy.